Showing 1911-1920 of 23131 results for "".
The Truth About The Latest Anti-Obesity Medications
https://reachmd.com/programs/everyday-family-medicine/truth-about-latest-anti-obesity-medications/7431/What’s the truth about latest anti-obesity medications? How do clinicians assess their safety and efficacy to select the appropriate treatment option for patients? To discuss the latest on anti-obesity medications, host Dr. Jennifer Caudle welcomes Dr. Adarsh K. Gupta, Director of the Center for MedContact Lens Success in Modern Optometric Clinics
https://reachmd.com/empower-business-specialty-care-optometric-series/march-april-2026-supplement/contact-lens-success-in-modern-optometric-clinics/49028/Daily contact lens patients live their best lives when providers match their anatomy and needs to the lens that fits them best.A Human CLINICAL Trial of Engineered ASCT
https://reachmd.com/programs/clinicians-roundtable/a-human-clinical-trial-of-engineered-asct/1113/Tens of thousands of autologous stem cell transplants are performed each year to treat blood cancer. Is there a way to increase the long term success rates?Groundbreaking AI Models Transform Cardiovascular Diagnosis
https://reachmd.com/programs/medical-industry-feature/groundbreaking-ai-models-transform-cardiovascular-diagnosis/29925/Discover how new AI models are leveraging cardiac imaging to detect structural heart disease earlier and expand access to life-saving screening.Psoriasis Challenges and Alopecia Areata Advances
https://reachmd.com/programs/practical-dermatology/psoriasis-challenges-and-alopecia-areata-advances/39885/Mona Shahriari, MD, FAAD, talks about the challenges psoriasis poses in certain parts of the body such as the scalp and nails, plus Brittany Craiglow, MD, FAAD, joins Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, to discuss the latest advances in alopecia areata.Injectable Medication as an Alternative Treatment for Diabetic Eye Disease
https://reachmd.com/programs/the-jama-report/injectable-medication-alternative-treatment-diabetic-eye-disease/7767/[Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used to help reduce severe vision loss, but the proceNew Contact Lens Technology for Patients With Presbyopia, Dry Eye Disease, and Ocular Surface Disease
https://reachmd.com/empower-business-specialty-care-optometric-series/march-april-2026-supplement/new-contact-lens-technology-for-patients-with-presbyopia-dry-eye-disease-and-ocular-surface-disease/56897/A practical guide for new contact lens patients.Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
https://reachmd.com/programs/Audioabstracts/alectinib-vs-crizotinib-in-alk-nsclc-final-alex-data/56343/Long-term results from the ALEX trial reveal how first-line alectinib is reshaping survival expectations in ALK-positive non-small cell lung cancer (ALK+ NSCLC). In this AudioAbstract, hear Ryan Quigley break down the lasting impact of these findings on treatment decisions and patient outcomes.Factors Influencing the Selection of CSF Tests for Alzheimer Disease
https://reachmd.com/videos/neurology-in-motion/factors-influencing-the-selection-of-csf-tests-for-alzheimer-disease/35726/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of cerebrospinal fluid tests for Alzheimer disease.Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
https://reachmd.com/programs/neurofrontiers/amyloid-targeted-therapies-a-new-era-in-alzheimers-disease-treatment/29278/Explore the latest amyloid-targeted therapies and how they might lead to a multifaceted treatment approach for Alzheimer's disease.